We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
45 hedge funds and large institutions have $84.4M invested in Amphastar Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
2,709% more capital invested
Capital invested by funds: $3M → $84.4M (+$81.4M)
2,150% more funds holding
Funds holding: 2 → 45 (+43)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
45
Holders Change
+43
Holders Change %
+2,150%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$20.6M |
| 2 |
DM
Deerfield Management
New York
|
+$14.7M |
| 3 |
JP Morgan Chase
New York
|
+$7.81M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$6.88M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$5.98M |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$10.7K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.02K |
